Roche (OTCMKTS:RHHBY) Sets New 1-Year High – Here’s Why

Shares of Roche Holding AG (OTCMKTS:RHHBY) hit a new 52-week high on Monday . The company traded as high as $43.96 and last traded at $43.06, with a volume of 4303336 shares changing hands. The stock had previously closed at $43.89.

Analysts Set New Price Targets

Several analysts recently weighed in on RHHBY shares. Morgan Stanley began coverage on Roche in a research note on Wednesday, February 12th. They set an “equal weight” rating for the company. UBS Group upgraded Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 13th. Finally, Sanford C. Bernstein upgraded shares of Roche to a “strong-buy” rating in a research report on Thursday, January 30th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating, one has issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Roche Stock Performance

The business’s 50-day moving average is $39.31 and its 200 day moving average is $38.48. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. HighPoint Advisor Group LLC boosted its holdings in Roche by 2.8% in the fourth quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company’s stock valued at $387,000 after acquiring an additional 304 shares during the last quarter. Hantz Financial Services Inc. boosted its holdings in Roche by 0.9% during the 4th quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock worth $1,176,000 after acquiring an additional 305 shares during the last quarter. Canopy Partners LLC grew its position in Roche by 4.6% in the 3rd quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock worth $310,000 after purchasing an additional 344 shares in the last quarter. Brooklyn Investment Group lifted its holdings in Roche by 36.6% during the fourth quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock worth $48,000 after acquiring an additional 363 shares during the period. Finally, Altrius Capital Management Inc grew its position in Roche by 0.3% during the fourth quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock valued at $6,399,000 after buying an additional 603 shares during the period.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.